Trials / Active Not Recruiting
Active Not RecruitingNCT04255966
Plasmafit® Revision Structan® Hip Endoprosthesis Cup
Prospective, Multi-centric, Comparative, Long-term Clinical Follow-Up Study for the Evidence of Safety and Performance Indicators of the Plasmafit® Revision Structan® Hip Endoprosthesis Cup
- Status
- Active Not Recruiting
- Phase
- —
- Study type
- Observational
- Enrollment
- 60 (actual)
- Sponsor
- Aesculap AG · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The aim of this observational study is to collect clinical and radiological results of the new Plasmafit® Revision Structan® Hip Endoprosthesis Cup in a standard patient population and when used in routine clinical practice.
Conditions
- Osteolysis
- Arthroplasty Complications
- Instability of Prosthetic Joint
- Degenerative Osteoarthritis
- Rheumatic Arthritis
- Fractures, Hip
- Femoral Head Avascular Necrosis
- Prosthesis Failure
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | Plasmafit® Revision Structan® | Plasmafit® Revision Structan® Hip Endoprosthesis Cup |
Timeline
- Start date
- 2021-04-12
- Primary completion
- 2023-08-16
- Completion
- 2027-06-01
- First posted
- 2020-02-05
- Last updated
- 2025-04-29
Locations
4 sites across 1 country: Germany
Source: ClinicalTrials.gov record NCT04255966. Inclusion in this directory is not an endorsement.